Carotid Stenting and Endarterectomy: Equal Long Term Efficacy in Symptomatic Patients

Original title: Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Reference: Bonati LH et al. Lancet. 2014;Epub ahead of print.

 

Carotid stenting is an alternative to endarterectomy though long term efficacy remains unknown. This study reports the long term follow up of the International Carotid Stenting Study.

Patients with carotid artery symptomatic lesions were randomized 1:1 to endarterectomy vs. carotid stenting in 50 centers around the world. The events were assessed by an independent committee blind to assigned treatment. Primary end point was disabling or fatal stroke in any territory from randomization to end of follow up. Functional ability was measured with the modified Rankin scale. 1,713 patients were randomized to PCI (n=855) vs endarterectomy (n=858) and followed by a median of 4.2 years. 

The total number of disabling or fatal strokes was 52 for the PCI group and 49 for the surgery group, resulting in a similar accumulative risk at 5 years for both strategies (6.4% vs 6.5%; HR 1.06, IC 95% 0.7 to 1.57; p=0.77). 

Considering any stroke, more events were observed with stenting  (119 events vs 72) with an accumulated risk at 5 years of 15.2% vs 9.4% (HR 1.71, IC 95% 1.28 to 2.30; p<0.001) but events were mostly non disabling.  Score distribution in the modified Rankin scale at one year, 5 years or end of follow up were no different in the two groups.

Conclusion

Long term functional result as well as disabling or fatal stroke risk was similar for carotid stenting and endarterectomy in patients with symptomatic carotid artery lesions.

Editorial Comment

Increased minor stroke risk associated to carotid stenting should be counterbalanced with peri procedural infarction, brain damage and endarterectomy hematoma risks. 

This study has been criticized since the start; two of the most important objections are that only 70% of PCI procedures were performed with brain protection systems, and that most operators had little experience (only 10 previous carotid stenting procedures, or a tutor, was required).

SOLACI

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...